www.sec.gov/Archives/edgar/data/1124524/0001019687-09-0 -
[Cached Version]
Published on: 9/11/2009
Last Visited: 9/12/2009
Larry G. Stambaugh
Larry G. Stambaugh, age 62, was elected as the Company's Chairman of the Board on December 5, 2008 and became President and Chief Executive Officer on February 20, 2009.
Mr. Stambaugh is currently a Principal of Apercu Consulting, a firm that he established in 2006.
From December 1992 to January 2006, Mr. Stambaugh served as Chairman and Chief Executive Officer of Maxim Pharmaceuticals, a public company developing cancer and infectious disease drugs which he co-founded.
From December 2007 to February 2008, Mr. Stambaugh reorganized two biotechnology companies owned by Arrowhead Research Corporation, a public holding company, Calando Pharmaceuticals and Insert Therapeutics and served as Chief Executive Officer of each subsidiary.
Mr. Stambaugh has more than 30 years experience building global businesses and setting strategies and has an extensive background in life sciences and clean tech including relationships with and knowledge of Contract Research Organizations, biotech and pharmaceutical companies Mr. Stambaugh serves on several boards including EcoDog, Ridge Diagnostics, Corporate Directors Forum and BioCom.
Mr. Stambaugh earned his BBA Accounting/Finance from Washburn University in 1969.
...
Accordingly, Mr. Stambaugh would not be considered to be an independent director.